Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture vs Metformin for Insulin Resistance in PCOS
NCT02647827Phase 2Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Dec 2015
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) and insulin resistance (IR) (3 arms), sponsored by Karolinska Institutet. Primary endpoints: Homeostatic Model Assessment for Insulin Resistance at 4 months, Hemoglobin A1c at 4 months and 1 more. Started Dec 2015; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)insulin resistance (IR)
Beyond the preview
Go deeper on NCT02647827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647827.